m
Recent Posts
Connect with:
Tuesday / December 7.
HomemiproductsIluvien Implant for DME

Iluvien Implant for DME

Iluvien (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular oedema (DME) in patients who have been previously treated with corticosteroids and did not have a clinically significant rise in intraocular pressure.

Its continuous micro-dosing technology offers up to 36 months of treatment with a single implant. Iluvien comes in a pre-loaded injector system (pictured).

Contact: Specialised Therapeutics Australia (AUS) 1300 798 820 or (NZ) 9801 0299 

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.